Different therapeutic regimens continue to show promise in multiple myeloma
A number of therapeutic approaches are being evaluated for the treatment of multiple myeloma with very promising assets in the…
Latest Diagnostic and testing
-
8 months
-
8 months
-
8 months
-
11 months
-
8 months
-
8 months
-
8 months
-
11 months
Q&A: talking drug quality with Valisure, the first analytical pharmacy
In September 2019, the US Food and Drug Administration (FDA) recalled generic versions of Zantac (ranitidine) after impurities of the…
Latest News
View More
Novartis’ Zolgensma experiences further safety issues
Novartis has announced the US Food and Drug Administration (FDA) has placed a partial hold on the company’s Phase I/II STRONG study of spinal muscular…
FDA approves Grifols’ Xembify for immunodeficiencies
Spanish plasma-derived medicine specialist Grifols has announced that the US Food and Drug Administration (FDA) has approved its Xembify (immune globulin subcutaneous, human- klhw) for…
Company A-Z
View More
Latest Content
View More
Pharma Technology Focus: digitising the API supply chain
Pharma Technology Focus is now available on all devices. Read it for free here In March, US Food and Drug Administration…
Pharma Technology Focus: is a memory loss drug on the horizon?
Pharma Technology Focus is now available on all devices. Read it for free here In February, Johnson & Johnson’s depression drug…
Development and Production of the Respimat® Reuseable Inhaler Housing Module
Boehringer Ingelheim commissioned Gerresheimer to develop and produce on a large scale the housing module for the new generation of…
Technology Partners
Developed to nurture an ecosystem that digitises the workforce, Nymi unites a complete set of benefits aimed at onboarding teams…
Quality Statement
Nymi executed a Quality Management System (QMS) that aligns with its consumer demands and leads the development of products and…
Solution Overview
Healthcare industries struggle to deliver the advantages of digital transformation (DX), as commonplace solutions entail trade-offs between security, compliance, and…